{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:14:39Z","timestamp":1791188079473,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jaad.2012.02.042","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T19:48:04Z","timestamp":1336938484000},"page":"1055-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Germline melanoma susceptibility and prognostic genes: A review of the literature"],"prefix":"10.1016","volume":"67","author":[{"given":"Katherine A.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeAnn","family":"Lazovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Hordinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.02.042_bib1","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","article-title":"Genetics of melanoma predisposition","volume":"22","author":"Hayward","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2012.02.042_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK42 binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11912-000-0022-z","article-title":"New developments in melanoma genetics","volume":"2","author":"Hayward","year":"2000","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jaad.2012.02.042_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ng.411","article-title":"Genome-wide association study identifies three loci associated with melanoma risk","volume":"41","author":"Bishop","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.gene.6363726","article-title":"IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma","volume":"2","author":"Howell","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaad.2012.02.042_bib8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/carcin\/bgp207","article-title":"DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis","volume":"30","author":"Mocellin","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2012.02.042_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/bjc.1995.332","article-title":"Phenotype of glutathione S-transferase Mu (GSTM1) and susceptibility to malignant melanoma","volume":"72","author":"Lafuente","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib10","first-page":"498","article-title":"Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma","volume":"6","author":"Hutchinson","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/gene.2009.40","article-title":"Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case-control study","volume":"10","author":"Schoof","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaad.2012.02.042_bib12","first-page":"37","article-title":"Genetics of pigmentation and melanoma predisposition","volume":"145","author":"Pho","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2012.02.042_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02574493","article-title":"Melanoma and human leukocyte antigen status: the missing link?","volume":"9","author":"Sondak","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2012.02.042_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1755-148X.2009.00622.x","article-title":"Genome-wide associations: studies for melanoma and nevi","volume":"22","author":"Yeh","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib15","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/ijc.24622","article-title":"Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations","volume":"125","author":"Yang","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.hoc.2009.03.011","article-title":"Melanoma genetics: an update on risk-associated genes","volume":"23","author":"Udayakumar","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2012.02.042_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clindermatol.2008.09.005","article-title":"Melanoma and genetics","volume":"27","author":"Nelson","year":"2009","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1470-2045(06)71010-5","article-title":"Management of familial melanoma","volume":"8","author":"Bishop","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2012.02.042_bib19","first-page":"774","article-title":"Genetics in melanoma","volume":"6","author":"Stahl","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaad.2012.02.042_bib20","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK4a\/ARF locus and melanoma","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2012.02.042_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib23","first-page":"2289","article-title":"Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds","volume":"11","author":"Holland","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2012.02.042_bib24","first-page":"405","article-title":"Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma","volume":"11","author":"Liu","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2012.02.042_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/4.10.1845","article-title":"Mutations of the CDKN2\/p16INK4 gene in Australian melanoma kindreds","volume":"4","author":"Walker","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaad.2012.02.042_bib27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199510123331505","article-title":"Brief Report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene","volume":"333","author":"Whelan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.02.042_bib28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","article-title":"Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations","volume":"333","author":"Goldstein","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2012.02.042_bib29","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK4a\/ARF locus and melanoma","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2012.02.042_bib30","first-page":"109","article-title":"Novel mutations in the p16\/CDKN2A binding region of the cyclin-dependent kinase-4 gene","volume":"58","author":"Tsoa","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2133.1998.02020.x","article-title":"Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma","volume":"138","author":"Wagner","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.02.042_bib33","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1073\/pnas.95.14.8292","article-title":"Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2","volume":"95","author":"Kamijo","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2012.02.042_bib34","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.jaad.2012.02.042_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the RB and p53 tumor suppression pathways","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.02.042_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00439-009-0715-9","article-title":"Genetic risk factors for melanoma","volume":"126","author":"Meyle","year":"2009","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib37","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.20518","article-title":"Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas","volume":"47","author":"Helsing","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20202","article-title":"A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutations","volume":"44","author":"Molven","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CMR.0b013e3283287d3e","article-title":"Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia","volume":"19","author":"Pjanova","year":"2009","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/hmg\/ddh043","article-title":"Interactive effects of MC1R and OCA2 on melanoma risk phenotypes","volume":"13","author":"Duffy","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0749.2000.130203.x","article-title":"a key messenger in the regulation of skin pigmentation","volume":"13","author":"Busca","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/hmg\/5.10.1663","article-title":"The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma","volume":"5","author":"Valverde","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(93)90572-8","article-title":"Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function","volume":"72","author":"Robbins","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.02.042_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.ge.28.120194.001201","article-title":"Molecular and developmental genetics of mouse coat color","volume":"28","author":"Jackson","year":"1994","journal-title":"Ann Rev Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1034\/j.1600-0749.2003.00041.x","article-title":"The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes","volume":"16","author":"Sturm","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.jidsp.5640177","article-title":"Participation of the melanocortin-1 receptor in the UV control of pigmentation","volume":"4","author":"Suzuki","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2012.02.042_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-1119(01)00694-1","article-title":"Human pigmentation genes: identification, structure and consequences of polymorphic variation","volume":"277","author":"Sturm","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.jaad.2012.02.042_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1006\/bbrc.1998.8459","article-title":"Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor","volume":"245","author":"Frandberg","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaad.2012.02.042_bib50","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1006\/bbrc.1999.0935","article-title":"Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair","volume":"260","author":"Schioth","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaad.2012.02.042_bib51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/1523-1747.ep12480680","article-title":"Pheomelanin as well as eumelanin is present in human epidermis","volume":"97","author":"Thody","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib52","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1523-1747.2000.00977.x","article-title":"Microanalysis of melanins in mammalian hair by alkaline hydrogen peroxide degradation: identification of a new structural marker of pheomelanins","volume":"114","author":"Napolitano","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib53","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/jid.2010.48","article-title":"Protection against UVR involves MC1R-mediated non-pigmentary and pigmentary mechanisms in\u00a0vivo","volume":"130","author":"Robinson","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib55","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.23396","article-title":"MC1R variants, melanoma and red hair color phenotype: a meta-analysis","volume":"122","author":"Raimondi","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib56","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ejca.2009.02.001","article-title":"MC1R variant alleles and malignant melanoma risk in Israel","volume":"45","author":"Galore-Haskel","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?","volume":"66","author":"Palmer","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00403-006-0708-7","article-title":"Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma","volume":"298","author":"M\u00f6ssner","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib59","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/djr219","article-title":"Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma","volume":"103","author":"Chatzinasiou","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2012.02.042_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib61","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/323411","article-title":"Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma","volume":"69","author":"van der Velden","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib62","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1600-0625.2009.00846.x","article-title":"Pigmentation-related genes and their implication in malignant melanoma susceptibility","volume":"18","author":"Fernandez","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib63","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ng.161","article-title":"ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma","volume":"48","author":"Gudbjartsson","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib64","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ng.160","article-title":"Two newly identified genetic determinants of pigmentation in Europeans","volume":"40","author":"Sulem","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib65","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ijc.24327","article-title":"Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians","volume":"125","author":"Nan","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.163","article-title":"Common sequence variants on 20q11.22 confer melanoma susceptibility","volume":"40","author":"Brown","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib67","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/339076","article-title":"A polymorphism in the agouti signaling protein gene is associated with human pigmentation","volume":"70","author":"Kanetsky","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib68","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1074\/jbc.275.16.12281","article-title":"A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature","volume":"275","author":"Berson","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2012.02.042_bib69","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.ejhg.5201415","article-title":"Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma","volume":"13","author":"Jannot","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib70","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/humu.20804","article-title":"SLC45A2: a novel malignant melanoma-associated gene","volume":"29","author":"Fernandez","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2012.02.042_bib71","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/humu.20823","article-title":"Variants of the MATP\/SLC45A2 gene are protective for melanoma in the French population","volume":"29","author":"Guedj","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2012.02.042_bib72","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/jid.2009.258","article-title":"Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma","volume":"130","author":"Duffy","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib73","first-page":"69","article-title":"Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiological studies","volume":"12","author":"Whiteman","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jaad.2012.02.042_bib74","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/0003-4819-102-4-458","article-title":"High risk of malignant melanoma in melanoma-prone families with dysplastic nevi","volume":"102","author":"Greene","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2012.02.042_bib75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ng.410","article-title":"Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi","volume":"41","author":"Falchi","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib76","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/hmg\/ddr154","article-title":"Genome-wide associated study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk","volume":"20","author":"Nan","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1000074","article-title":"A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation","volume":"4","author":"Han","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib78","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.2007.13","article-title":"Genetic determinants of hair, eye and skin pigmentation in Europeans","volume":"39","author":"Sulem","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib79","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ajhg.2009.03.019","article-title":"Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation","volume":"84","author":"Wang","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2370.2003.00425.x","article-title":"Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma","volume":"30","author":"Howell","year":"2003","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaad.2012.02.042_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910550212","article-title":"Analysis of antigens recognised on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL)","volume":"55","author":"Wolfel","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/CMR.0b013e32830658b2","article-title":"Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma","volume":"18","author":"Gu","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-5699(84)90152-X","article-title":"Depressed immunity and skin cancer","volume":"5","author":"Penn","year":"1984","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaad.2012.02.042_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00008390-200502000-00009","article-title":"Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease","volume":"15","author":"Alonso","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphisms in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaad.2012.02.042_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/030097498441029","article-title":"IL-10 gene promoter polymorphisms in rheumatoid arthritis","volume":"27","author":"Hajeer","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib87","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00008390-200209000-00008","article-title":"Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients","volume":"12","author":"Martinez-Escribano","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00262-006-0193-z","article-title":"Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population","volume":"56","author":"Nikolova","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaad.2012.02.042_bib89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-199502000-00008","article-title":"Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma","volume":"5","author":"Dummer","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib90","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E","article-title":"Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules","volume":"71","author":"Yue","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib91","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/1078-0432.1237.11.3","article-title":"Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study","volume":"11","author":"Liu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-6-6","volume":"6","author":"von Euw","year":"2008","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaad.2012.02.042_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2370.2002.00269.x","article-title":"Influence of TNF\u03b1 and LT\u03b1 single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population","volume":"29","author":"Howell","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaad.2012.02.042_bib94","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2133.2005.06896.x","article-title":"HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor","volume":"154","author":"Planelles","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-0039.1996.tb02523.x","article-title":"The human leukocyte antigen TAP2 gene defines the centromeric limit of melanoma susceptibility on chromosome 6p","volume":"47","author":"Lee","year":"1996","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2012.02.042_bib96","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ijc.2910590413","article-title":"HLA-DQB1*0301 association with increased cutaneous melanoma risk","volume":"59","author":"Lee","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib97","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<758::AID-CNCR11>3.0.CO;2-U","article-title":"Malignant melanoma: relationship of the human leukocyte antigen class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer stage I or II","volume":"78","author":"Lee","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib98","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00002371-199511000-00005","article-title":"HLA associations in the antitumor response against malignant melanoma","volume":"18","author":"Marincola","year":"1995","journal-title":"J Immunother"},{"key":"10.1016\/j.jaad.2012.02.042_bib99","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00002371-199811000-00005","article-title":"Molecular analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients","volume":"21","author":"Lombardi","year":"1998","journal-title":"J Immunother"},{"key":"10.1016\/j.jaad.2012.02.042_bib100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1399-0039.1998.tb03102.x","article-title":"HLA-DR and \u2013DQ alleles in Italian patients with melanoma","volume":"51","author":"Lulli","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2012.02.042_bib101","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1399-0039.1997.tb02780.x","article-title":"Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma","volume":"49","author":"Kageshita","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2012.02.042_bib102","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1399-0039.1998.tb03025.x","article-title":"HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population","volume":"52","author":"Bateman","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaad.2012.02.042_bib103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.cmr.0000198450.19204.dd","article-title":"High risk of cutaneous melanoma amongst carriers of the intercellular adhesion molecule-1 R241 allele","volume":"16","author":"Vinceti","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00202069","article-title":"Intercellular adhesion molecule-1","volume":"74","author":"van de Stolpe","year":"1996","journal-title":"J Mol Med"},{"key":"10.1016\/j.jaad.2012.02.042_bib105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/molehr\/gag002","article-title":"Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis","volume":"9","author":"Vigano","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jaad.2012.02.042_bib106","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0092-8674(91)90548-D","article-title":"Binding of the\u00a0integrin Mac-1 (CD11b\/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation","volume":"65","author":"Diamond","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2012.02.042_bib107","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/carcin\/bgl257","article-title":"DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma","volume":"28","author":"Povey","year":"2007","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.jaad.2012.02.042_bib108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mrgentox.2010.06.011","article-title":"Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma","volume":"702","author":"Figl","year":"2010","journal-title":"Mutat Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib109","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.2009.09219.x","article-title":"Polymorphisms in genes involved in DNA repair, cell growth, oxidative stress, and inflammatory response and melanoma risk","volume":"161","author":"Gu","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mrfmmm.2008.11.011","article-title":"Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients","volume":"661","author":"Figl","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib111","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1158\/1078-0432.CCR-08-2678","article-title":"Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma","volume":"15","author":"Firoz","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2012.02.042_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10689-008-9206-8","article-title":"Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin","volume":"8","author":"Kadouri","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib113","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/carcin\/bgl042","article-title":"Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma","volume":"27","author":"Li","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2012.02.042_bib114","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1055-9965.EPI-06-0672","article-title":"Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis","volume":"15","author":"Li","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2012.02.042_bib115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00439-010-0921-5","article-title":"Genetic variants in telomere-maintaining genes and skin cancer risk","volume":"129","author":"Nan","year":"2011","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaad.2012.02.042_bib116","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/carcin\/13.6.1035","article-title":"Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility","volume":"13","author":"Wolf","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2012.02.042_bib117","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/carcin\/16.11.2675","article-title":"Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls","volume":"16","author":"Dolzan","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2012.02.042_bib118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00008571-199906000-00001","article-title":"Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma","volume":"9","author":"Strange","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jaad.2012.02.042_bib119","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1389200043335621","article-title":"Cytochrome P450 gene polymorphism and cancer","volume":"5","author":"Ag\u00fandez","year":"2004","journal-title":"Current Drug Metab"},{"key":"10.1016\/j.jaad.2012.02.042_bib120","first-page":"859","article-title":"Significance of glutathione S-transferases M1, T1, and P1 polymorphisms in Swedish melanoma patients","volume":"17","author":"Bu","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jaad.2012.02.042_bib121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1097-0215(20010101)91:1<55::AID-IJC1006>3.0.CO;2-4","article-title":"Altered glutathione antioxidant metabolism during tumor progression in human renal-cell carcinoma","volume":"91","author":"Lusini","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib122","first-page":"49","article-title":"The glutathione S-transferases: their role in detoxification and toxification of xenobiotics","volume":"38","author":"Baars","year":"1980","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.jaad.2012.02.042_bib123","first-page":"733","article-title":"Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility","volume":"6","author":"Rebbeck","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2012.02.042_bib124","first-page":"509","article-title":"Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma","volume":"10","author":"Kanetsky","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2012.02.042_bib125","first-page":"69","article-title":"Genetic susceptibility to environmental carcinogenesis in Slovenian melanoma patients","volume":"15","author":"Dolzan","year":"2006","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.jaad.2012.02.042_bib126","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2133.2006.07620.x","article-title":"Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism","volume":"156","author":"Santonocito","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib127","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jsbmb.2004.03.002","article-title":"Differential biological effects of 1,25-dihydroxyvitamin D3 on melanoma cell lines in\u00a0vitro","volume":"89-90","author":"Seifert","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jaad.2012.02.042_bib128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jn\/135.2.310","article-title":"Vitamin D intake: a global perspective of current status","volume":"135","author":"Calvo","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.jaad.2012.02.042_bib129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgp103","article-title":"Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk","volume":"30","author":"Raimondi","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2012.02.042_bib130","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.85.10.3294","article-title":"Cloning and expression of full-length cDNA encoding human vitamin D receptor","volume":"85","author":"Baker","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2012.02.042_bib131","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.jid.5700544","article-title":"Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma","volume":"127","author":"Li","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2012.02.042_bib132","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4161\/derm.1.1.7674","article-title":"The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma","volume":"1","author":"Halsall","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jaad.2012.02.042_bib133","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/ijc.23357","article-title":"Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study","volume":"122","author":"Li","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib134","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ejca.2008.10.003","article-title":"Vitamin D and skin cancer: a meta-analysis","volume":"45","author":"Gandini","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2012.02.042_bib135","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1200\/JCO.2009.22.1135","article-title":"Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma","volume":"27","author":"Newton-Bishop","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2012.02.042_bib136","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(02)00894-X","article-title":"Genetic testing for melanoma","volume":"3","author":"Kefford","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2012.02.042_bib137","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.1999.17.10.3245","article-title":"Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium","volume":"17","author":"Kefford","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2012.02.042_bib138","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2133.2008.08682.x","article-title":"Genetics of melanoma predisposition","volume":"159","author":"Lin","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212002769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212002769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:25:55Z","timestamp":1759271155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212002769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0190962212002769"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.02.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline melanoma susceptibility and prognostic genes: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2012.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}